International Stem Cell Corporation Creating The First Bank Of Immune-Matched Human Parthenogenetic Stem Cells
International Stem Cell Corporation announced that its oocyte collection and activation protocol has received the approval of an Institutional Review Board, a Federal requirement for all studies enrolling human subjects, and ensures appropriate subject safety and monitoring to protect subjects from unnecessary medical risks.
